This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Wuhan University, Yanti University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 172 
1 out of 1 Years Active: 2016
Title: Meng Wen: Innovator in Anti-Tumor Medicaments
Introduction
Meng Wen is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor medications. His innovative work has led to the creation of a unique compound that holds promise for cancer treatment.
Latest Patents
Meng Wen holds a patent for a pyrazolo[1,5-A]pyrimidine derivative, which is described as a compound with potential anti-tumor properties. The patent details the general formula of the compound and its pharmaceutically acceptable salts. This invention is aimed at providing a new avenue for the preparation of anti-tumor medicaments, showcasing Meng's commitment to advancing medical science.
Career Highlights
Throughout his career, Meng Wen has been associated with prestigious institutions such as Yantai University and Wuhan University. His work in these academic environments has allowed him to collaborate with other researchers and contribute to the advancement of pharmaceutical sciences.
Collaborations
Meng has worked alongside notable colleagues, including Mingmin Ding and Xi Zhu. Their collaborative efforts have further enriched the research landscape in which Meng operates.
Conclusion
Meng Wen's innovative contributions to anti-tumor medication development highlight his role as a significant figure in the pharmaceutical industry. His patent and collaborations reflect a dedication to improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile